Company Overview of n.v. BRUCELLS s.a.
n.v. BRUCELLS s.a. is out of business. The company engages in the development of therapeutic cancer vaccines using dendritic cells. It develops dendritic cells fused with whole tumor cells; dendritic cells loaded ex-vivo with proteins or peptides associated with tumor antigens; BCL002 vaccine for skin cancer; BCL003 vaccine for cancers of the brain and nervous system; BCL004 vaccine for kidney cancer; and BCL005 vaccine for skin cancer. The company was incorporated in 2001 and is based in Brussels, Belgium.
Avenue Baden Powell 3
Founded in 2001
32 2 772 45 57
32 2 772 45 57
Key Executives for n.v. BRUCELLS s.a.
n.v. BRUCELLS s.a. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Apotheek Delestre NV||Europe|
|Apotheek Moons NV||Europe|
|Apotheek Philips NV||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact n.v. BRUCELLS s.a., please visit www.brucells.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.